Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain

National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain

The purpose of this study is to evaluate the efficacy and safety of Canadá association in the treatment of chronic pain

Inclusion Criteria:

• Ability to confirm voluntary participation and agree to all trial purposes by signing and dating the consent form;
• Chronic pain during at least 3 months.

Exclusion Criteria:

• Any clinical and laboratory findings that, in the judgment of the investigator, may interfere with the safety of participants;
• History of alcohol abuse or illicit drug use;
• Participation in a clinical trial in the year prior to this study;
• Pregnancy or risk of pregnacy and lactating participants;
• Known hypersensitivity to any of the formula compounds.